All Bacteria articles – Page 14
-
NewsYeast in gut microbiome can worsen salmonella infection
Researchers have discovered that a yeast commonly found in our gut can make infection with salmonella worse. Salmonella binds to Candida albicans and triggers a chain reaction that allows the bacteria to better invade cells lining the intestines.
-
NewsStudy identifies hotspots of disease-carrying ticks in Illinois
Scientists analyzed the distribution of three potentially harmful tick species in Illinois, identifying regions of the state with higher numbers of these ticks and, therefore, at greater risk of infection with multiple tick-borne diseases.
-
NewsMolecular roadmap links stomach infection to cancer risk
A new study has identified protein signatures that trace the trajectory from Helicobacter pylori infection to the progression of gastric lesions and eventual cancer. Researchers pinpointed 28 proteins that change consistently during this process.
-
NewsIncidence of specific antibiotic-resistant bacteria increased 69% between 2019 and 2023
A brief research report found that incidence of a specific antibiotic-resistant bacteria increased 69% between 2019 and 2023. The report described trends in incidence of carbapenemase-producing carbapenem-resistant Enterobacterales clinical isolates reported to the CDC.
-
NewsThe role of the microbiome in the successful transplantation of Posidonia oceanica seagrass meadows
A study of seagrass restoration shows that transplantation method directly influences the root microbiome, which is essential for the survival of the plants - paving the way for more effective and sustainable restoration techniques.
-
NewsBeer and wine: the latest microbe-related discoveries
To produce haziness, researchers added yeast extracts to two brands of clear lager - and reported what happened. Another team carried out lab tests investigating how sulfites added to wine and an ethanol-containing liquid affect gut bacteria.
-
NewsScientists discover powerful new antibiotic class to tackle deadly superbugs
Scientists have discovered Novltex, a new class of antibiotics with potent activity against some of the world’s most dangerous multidrug-resistant (MDR) bacteria. It targets lipid II — an essential building block of bacterial cell walls that does not mutate.
-
NewsNew genome editing method inspired by bacteria’s defense strategies
Researchers have developed a new method for precisely editing DNA. Their aim was to make genetic changes in bacteria, plants, and human cells even more accurate and gentle.
-
NewsResearch breakthrough offers hope for new colorectal cancer treatments
Researchers have identified the key mechanism by which Fusobacterium nucleatum binds to the human cell receptors CEACAM1 and CEACAM5, which are frequently overexpressed on many types of cancer cells.
-
NewsTuberculosis vulnerability of people with HIV: a viral protein implicated
Tuberculosis accounts for one in three deaths among people living with HIV. A new study highlights the key role played by Tat 2 – a viral protein secreted by HIV-infected cells – in this hyper-vulnerability phenomenon.
-
NewsOral microbes linked to increased risk of pancreatic cancer
Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study shows.
-
NewsSpecial lactic acids reduce antibiotic resistance in infants
Researchers document that a special subgroup of naturally occurring bifidobacteria plays a crucial role in reducing antibiotic resistance in infants.
-
NewsBlood microbial DNA distinguishes liver cancer from metastatic lesions
A simple blood test analyzing microbial DNA could help doctors tell apart primary liver cancer from colorectal cancer that has spread to the liver, according to a new study.
-
NewsStudy finds ticks carrying Lyme disease moving into western NC
A new surveillance study reveals that the primary vector of the bacteria that cause Lyme disease, the blacklegged tick, has been spreading into areas previously considered low risk.
-
NewsResearchers find a more precise way to edit the genome
A genome-editing technique known as prime editing holds potential for treating many diseases. However, the process carries a small chance of inserting errors that could be harmful - but researchers have now found a way to dramatically lower the error rate.
-
NewsAI-powered CRISPR could lead to faster gene therapies, study finds
A new AI tool can help scientists better plan gene-editing experiments. CRISPR-GPT acts as a gene-editing “copilot” supported by AI to help researchers — even those unfamiliar with gene editing — generate designs, analyze data and troubleshoot design flaws.
-
NewsNew CRISPR test could make tuberculosis screening as simple as a mouth swab
Researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, a potential breakthrough that could allow easier, community-based screenings for the world’s deadliest infectious disease.
-
NewsMicrobiotica announces completion of recruitment in its international phase 1b trial of microbiome co-therapy
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient recruitment is complete in its advanced melanoma (MELODY-1) trial.
-
NewsNew Center of Excellence to respond to the challenge of antibiotic-resistant bacteria
Boston Children’s Hospital and Tulane University have received $25 million in funding from NIAID/NIH to establish a Center of Excellence for Translational Research (CETR) called IMPACT (Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity).
-
NewsCholera kills more people for second consecutive year, while prevention and treatment available
The World Health Organization (WHO) has published its global cholera statistics for 2024, showing an increase in both the number of people who fell sick and died from the disease. Reported cholera cases rose by 5% and deaths by 50% in 2024 compared to 2023.